BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2684167)

  • 21. Synthesis and pharmacological activity of partially modified retro-inverso dermorphin tetrapeptides.
    Salvadori S; Marastoni M; Balboni G; Sarto GP; Tomatis R
    J Med Chem; 1985 Jun; 28(6):769-74. PubMed ID: 4009598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs].
    Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA
    Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptides related to the dermorphins. II. Synthesis and biological activities of new analogues.
    Melchiorri P; Erspamer GF; Erspamer V; Guglietta A; De Castiglione R; Faoro F; Perseo G; Piani S; Santangelo F
    Peptides; 1982; 3(5):745-8. PubMed ID: 7177920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermorphin analogs: resistance to in vitro enzymatic degradation is not always increased by additional D-amino acid substitutions.
    Darlak K; Benovitz DE; Spatola AF; Grzonka Z
    Biochem Biophys Res Commun; 1988 Oct; 156(1):125-30. PubMed ID: 2902857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of carboxyl terminally extended dermorphins.
    Marastoni M; Salvadori S; Balboni G; Marzola G; degli Uberti EC; Tomatis R
    Int J Pept Protein Res; 1986 Sep; 28(3):274-81. PubMed ID: 3781741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase.
    Chaki K; Sakurada S; Sakurada T; Kisara K; Suzuki K
    Life Sci; 1990; 46(23):1671-8. PubMed ID: 1972532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the degradation of dermorphin and D-Arg2-dermorphin analogs by a soluble rat brain extract.
    Sasaki Y; Hosono M; Matsui M; Fujita H; Suzuki K; Sakurada S; Sakurada T; Kisara K
    Biochem Biophys Res Commun; 1985 Aug; 130(3):964-70. PubMed ID: 2862871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydro-dermorphins. I. Influence of the stereo-orientation of aromatic groups in dermorphin-(1-5)-peptides to opioid activity.
    Salvadori S; Marastoni M; Balboni G; Marzola G; Tomatis R
    Int J Pept Protein Res; 1986 Sep; 28(3):254-61. PubMed ID: 3781739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic tetrapeptides related to dermorphin: potent long lasting analgesic action following subcutaneous administration.
    Salvadori S; Marastoni M; Balboni G; degli Uberti E; Tomatis R
    Peptides; 1985; 6 Suppl 3():127-9. PubMed ID: 3831956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC; Schiller PW
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid peptides. Conformational studies of dermorphin and its constitutive fragments by circular dichroism. IX.
    Scatturin A; Salvadori S; Vertuani G; Tomatis R
    Farmaco Sci; 1985 Oct; 40(10):709-16. PubMed ID: 4085639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological activity of dermorphin and its N-terminal sequences.
    Salvadori S; Sarto G; Tomatis R
    Int J Pept Protein Res; 1982 May; 19(5):536-42. PubMed ID: 6889583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid peptides. VIII. Synthesis and preliminary biological activity of [D-Phe3]- or [alpha,beta-dehydro-Phe3]dermorphin tetrapeptides.
    Salvadori S; Marastoni M; Balboni G; Tomatis R
    Farmaco Sci; 1985 Jun; 40(6):454-8. PubMed ID: 4029390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid peptides. Biological study of [D-MetO2] dermorphin analogues in relation to the plurality of opioid receptors. XI.
    Marastoni M; Salvadori S; Tomatis R; Borea PA; Bertelli G
    Farmaco Sci; 1987 Feb; 42(2):125-31. PubMed ID: 3032674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological studies of dermorphin and its analogs substituted at positions 5 and 7.
    Sivanandaiah KM; Gurusiddappa S; Babu VV
    Int J Pept Protein Res; 1989 Jun; 33(6):463-7. PubMed ID: 2570771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies of dermorphin. Synthesis and some pharmacological data of dermorphin and its 1-substituted analogues.
    Darłak K; Grzonka Z; Janicki P; Członkowski A; Gumułka SW
    J Med Chem; 1983 Oct; 26(10):1445-7. PubMed ID: 6312044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Conformation-activity relations of dermorphin and its pentapeptide analogs].
    Shenderovich MD; Liepinia IT; Nikiforovich GV; Sumbatian NV; Korshunova GA; Shvachkin IuP
    Bioorg Khim; 1989 Sep; 15(9):1161-72. PubMed ID: 2556149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion.
    degli Uberti EC; Trasforini G; Salvadori S; Margutti A; Tomatis R; Rotola C; Bianconi M; Pansini R
    Neuroendocrinology; 1983 Oct; 37(4):280-3. PubMed ID: 6633818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII.
    Salvadori S; Marastoni M; Balboni G; Tomatis R; Borea PA
    Farmaco Sci; 1987 Dec; 42(12):931-40. PubMed ID: 2896601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid peptide. Structure-activity relationships in dermorphin tetrapeptide-amides. II.
    Salvadori S; Tomatis R; Sarto G
    Farmaco Sci; 1982 Oct; 37(10):669-73. PubMed ID: 7140967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.